- Home
- LVO vs CTOR Comparison
LVO vs CTOR Comparison
Compare LVO & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- CTOR
- Stock Information
- Founded
- LVO 2009
- CTOR 2021
- Country
- LVO United States
- CTOR United States
- Employees
- LVO N/A
- CTOR N/A
- Industry
- LVO Restaurants
- CTOR
- Sector
- LVO Consumer Discretionary
- CTOR
- Exchange
- LVO Nasdaq
- CTOR NYSE
- Market Cap
- LVO 72.9M
- CTOR 63.7M
- IPO Year
- LVO N/A
- CTOR N/A
- Fundamental
- Price
- LVO $0.75
- CTOR $2.87
- Analyst Decision
- LVO Strong Buy
- CTOR Buy
- Analyst Count
- LVO 1
- CTOR 2
- Target Price
- LVO $1.50
- CTOR $6.00
- AVG Volume (30 Days)
- LVO 935.9K
- CTOR 2.7M
- Earning Date
- LVO 08-12-2025
- CTOR 08-11-2025
- Dividend Yield
- LVO N/A
- CTOR N/A
- EPS Growth
- LVO N/A
- CTOR N/A
- EPS
- LVO N/A
- CTOR N/A
- Revenue
- LVO $114,405,000.00
- CTOR N/A
- Revenue This Year
- LVO N/A
- CTOR N/A
- Revenue Next Year
- LVO $23.84
- CTOR N/A
- P/E Ratio
- LVO N/A
- CTOR N/A
- Revenue Growth
- LVO N/A
- CTOR N/A
- 52 Week Low
- LVO $0.55
- CTOR $0.55
- 52 Week High
- LVO $1.82
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- LVO 47.15
- CTOR N/A
- Support Level
- LVO $0.76
- CTOR N/A
- Resistance Level
- LVO $0.92
- CTOR N/A
- Average True Range (ATR)
- LVO 0.07
- CTOR 0.00
- MACD
- LVO -0.00
- CTOR 0.00
- Stochastic Oscillator
- LVO 34.78
- CTOR 0.00
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.